Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Equities  >  Nasdaq  >  Intuitive Surgical, Inc.    ISRG

Delayed Quote. Delayed  - 09/28 10:00:00 pm
717.77 USD   -0.34%
09/25 INTUITIVE SURGI : Shares of Intuitive Surgical Sees Large Inflow of ..
09/13 INTUITIVE SURGI : My Top Bet on the Robotic Surgery Revolution
09/10 INTUITIVE SURGI : Reports New Employee Option Grants for September 2..
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector news 

Intuitive Surgical, Inc. : Intuitive Surgical 1Q Profit Up 38% On Strong Revenue

share with twitter share with LinkedIn share with facebook
share via e-mail
0
04/18/2012 | 12:14am CEST

--Intuitive Surgical tops first-quarter sales and earnings estimates

--Sales of da Vinci systems, procedure growth, fuel gains

--Company raises full-year guidance for sales, procedure growth

(Updates throughout with details on results and outlook)

 
   By Jon Kamp 
   Of  
 

Intuitive Surgical Inc.'s (ISRG) first-quarter earnings rose 38%, beating Wall Street expectations behind climbing sales of the company's da Vinci robotic-surgery machines and growth in procedures.

The Sunnyvale, Calif., company boosted its full-year forecasts for both revenue and procedure growth following the strong quarterly report. Shares--which are trading near all-time high levels and have climbed 18% on the year through Tuesday's close--rose 5.8%, to $576.98 in after-hours trading.

The company's motion-capture robots, which have been heavily used for cancer-treating surgeries, such as hysterectomies and prostate removal, have remained in strong demand despite continued economic turbulence and some sluggishness in Europe. The company sold 140 machines in the recent quarter, up 20 from a year ago, and posted 29% growth in procedures.

The company saw strong growth in both general-surgery and gynecological procedures, Chief Executive Gary Guthart said on a conference call with analysts. Newly introduced da Vinci instruments also helped fuel rising sales.

Intuitive Surgical reported a profit of $143.5 million, or $3.50 a share, up from $104.1 million, or $2.59 a share, a year earlier. Revenue increased 28%, to $495.2 million.

Analysts polled by Thomson Reuters most recently projected earnings of $3.14 on revenue of $464.7 million.

Gross margin edged up to 71.9% from 71.8%.

Revenue from instruments and accessories climbed 32%, reflecting growth in da Vinci procedures and the roll-out of new products. Revenue from service deals for da Vinci machines jumped 27%. Systems revenue, reflecting newly sold machines, grew 24%.

Da Vinci systems sold for nearly $1.5 million, on average, in the recent quarter.

Despite the overall strong sales, company officials said system sales in Europe were disappointing and below historical trends. They indicated the company is working to bolster its marketing efforts there.

"European system sales reflect a challenging economic environment, however, we are also taking steps to improve our execution," Chief Financial Officer Marshall Mohr said on the conference call.

Looking ahead, Intuitive Surgical now anticipates revenue growth of 19% to 21% this year, up from the company's prior 17% to 19% forecast. The company's new guidance calls for procedure growth of 25% to 27%, up from the prior 24% to 26% target.

Analysts had forecast, on average, sales growth of about 18% this year.

-By Jon Kamp, Dow Jones Newswires; 617-654-6728; jon.kamp@dowjones.com

--Tess Stynes contributed to this article.

Order free Annual Report for Intuitive Surgical, Inc.

Visit http://djnweurope.ar.wilink.com/?ticker=US46120E6023 or call +44 (0)208 391 6028

share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on INTUITIVE SURGICAL, INC.
09/25 INTUITIVE SURGICAL : Shares of Intuitive Surgical Sees Large Inflow of Net Money..
09/13 INTUITIVE SURGICAL : My Top Bet on the Robotic Surgery Revolution
09/10 INTUITIVE SURGICAL : Reports New Employee Option Grants for September 2016
09/09 Intuitive Surgical Reports New Employee Option Grants for September 2016
09/02 SUNNYVALE : Commission reviews two projects that plan to work together
08/19 INTUITIVE SURGICAL : Reports New Employee Option Grants for August 2016
08/17 Intuitive Surgical Reports New Employee Option Grants for August 2016
08/17 INTUITIVE SURGICAL : New Study Shows Robotic-Assisted Surgery Benefits For Ventr..
08/16 New Study Shows Robotic-Assisted Surgery Benefits For Ventral Hernia Patients
08/04 DEXTERA SURGICAL : DXTR) Enters Joint Development Program with Intuitive Surgica..
More news
Sector news : Advanced Medical Equipment & Technology - NEC
09/27DJBOSTON SCIENTIFIC : to Buy EndoChoice
09/01DJPHILIPS : Appoints IBM Executive Sophie Bechu as Operations Head
08/17DJAGILENT TECHNOLOGIES : Tech Tapers Annual Outlook Amid Slowing Life Sciences Sal..
08/15DJFisher & Paykel Files Patent Infringement Claim Against ResMed
08/02DJCERNER : Edges Annual Revenue Guidance Lower
More sector news : Advanced Medical Equipment & Technology - NEC
News from SeekingAlpha
09/20 INTUITIVE SURGICAL : Future Bright, But Shares Overvalued
09/13 Steps To Survive The Rate Hike - Cramer's Mad Money (9/12/16)
09/02 Healthcare ratings roundup - new coverage
08/21 13 Buys And 7 Sells From The Wide-Moat Universe
07/26 Einhorn a buyer of Chemours; American Capital Agency among sales
Advertisement
Financials ($)
Sales 2016 2 647 M
EBIT 2016 1 041 M
Net income 2016 663 M
Finance 2016 1 447 M
Yield 2016 -
P/E ratio 2016 40,99
P/E ratio 2017 35,55
EV / Sales 2016 9,93x
EV / Sales 2017 8,92x
Capitalization 27 723 M
More Financials
Chart INTUITIVE SURGICAL, INC.
Duration : Period :
Intuitive Surgical, Inc. Technical Analysis Chart | ISRG | US46120E6023 | 4-Traders
Full-screen chart
Technical analysis trends INTUITIVE SURGICA...
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Technical analysis
Income Statement Evolution
More Financials
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 18
Average target price 742 $
Spread / Average Target 3,0%
Consensus details
EPS Revisions
More Estimates Revisions
Managers
NameTitle
Gary S. Guthart President, Chief Executive Officer & Director
Lonnie M. Smith Chairman
Marshall L. Mohr Chief Financial Officer & Senior Vice President
Myriam J. Curet Chief Medical Officer & Senior Vice President
Alan J. Levy Lead Independent Director
More about the company
Sector and Competitors
1st jan.Capitalization (M$)
INTUITIVE SURGICAL, IN..31.86%27 224
THERMO FISHER SCIENTIF..12.01%61 568
BOSTON SCIENTIFIC CORP..28.63%32 290
PHILIPS11.84%27 992
ILLUMINA, INC.-6.04%26 164
EDWARDS LIFESCIENCES C..53.48%25 320
More Results